ArticleDiscover oncology2024

Clinical and structural insights into the rare but oncogenic HER2-activating missense mutations in non-small cell lung cancer: a retrospective ATLAS cohort study.

Guangjian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.